Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Idrugs : the Investigational Drugs Journal
|
March 16, 2004
International Congress of Biological Psychiatry. 8-13 February 2004, Sydney, Australia
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
May 11, 2006
Prospects for the treatment of depression
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
August 2, 2017
Problematic medical marijuana, but not all cannabinoids?
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
October 12, 2011
The decline and fall of the psychopharmacology empire?
Trevor R Norman
Expert Opinion on Investigational Drugs
|
March 15, 2013
Agomelatine, melatonin and depressive disorder
Trevor R Norman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 17, 2006
Human embryonic stem cells: a resource for in vitro neuroscience research?
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
March 25, 2004
Mechanism of action of mirtazapine: dual action or dual effect?
Trevor R Norman
Psychopharmacology
|
February 22, 2012
The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?
Trevor R Norman
Expert Review of Neurotherapeutics
|
February 9, 2007
Emerging treatments for major depression
Trevor R Norman, Graham D Burrows
CNS Drugs
|
June 9, 2004
New formulations of existing antidepressants: advantages in the management of depression
Trevor R Norman, James S Olver
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Idrugs : the Investigational Drugs Journal
|
March 16, 2004
International Congress of Biological Psychiatry. 8-13 February 2004, Sydney, Australia
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
May 11, 2006
Prospects for the treatment of depression
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
August 2, 2017
Problematic medical marijuana, but not all cannabinoids?
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
October 12, 2011
The decline and fall of the psychopharmacology empire?
Trevor R Norman
Expert Opinion on Investigational Drugs
|
March 15, 2013
Agomelatine, melatonin and depressive disorder
Trevor R Norman
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 17, 2006
Human embryonic stem cells: a resource for in vitro neuroscience research?
Trevor R Norman
The Australian and New Zealand Journal of Psychiatry
|
March 25, 2004
Mechanism of action of mirtazapine: dual action or dual effect?
Trevor R Norman
Psychopharmacology
|
February 22, 2012
The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?
Trevor R Norman
Expert Review of Neurotherapeutics
|
February 9, 2007
Emerging treatments for major depression
Trevor R Norman, Graham D Burrows
CNS Drugs
|
June 9, 2004
New formulations of existing antidepressants: advantages in the management of depression
Trevor R Norman, James S Olver
Page
of 5